Patent · US Active

Pyruvate kinase activators for use in therapy

US9682080B2 · kind B2 · utility

11Cited by
5References
30Claims
0Family size

Assignee

Inventor

Key dates

Filing dateOct 19, 2015
Grant dateJun 20, 2017
Priority date—
Expiry dateOct 19, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D307/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein are methods for using compounds that activate pyruvate kinase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.